Colon Cancer Research - Causes, Treatment, Symptoms

Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.


Colon Cancer Research Today

Home

View Latest Issue

Information About Colon Cancer

Books on Colon Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 9 (September)

  1. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.
    Am J Epidemiol, 162(6): 548-58. [Abstract] [Full-text]
  2. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Cancer Res, 65(17): 8022-7. [Abstract] [Full-text]
  3. Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects.
    Cancer Res, 65(17): 7832-9. [Abstract] [Full-text]
  4. Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation.
    Cancer Res, 65(17): 7809-14. [Abstract] [Full-text]
  5. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men.
    Eur J Cancer, 41(13): 1911-22. [Abstract] [Full-text]
  6. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
    Dis Colon Rectum, 48(9): 1714-22. [Abstract] [Full-text]
  7. Integrity of the anal sphincters after pouch-anal anastomosis: evaluation with three-dimensional endoanal ultrasonography.
    Dis Colon Rectum, 48(9): 1728-35. [Abstract] [Full-text]
  8. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat.
    Dis Colon Rectum, 48(9): 1708-13. [Abstract] [Full-text]
  9. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
    J Cancer Res Clin Oncol, 131(8): 504-10. [Abstract] [Full-text]
  10. Deep infiltrative low-grade MALT (mucosal-associated lymphoid tissue) colonic lymphomas that regressed as a result of antibiotic administration: endoscopic ultrasound evaluation.
    J Gastroenterol, 40(8): 843-7. [Abstract] [Full-text]
  11. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers.
    Gastroenterology, 129(3): 1047-59. [Abstract] [Full-text]
  12. Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo.
    Gastroenterology, 129(3): 952-68. [Abstract] [Full-text]
  13. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.
    Gastroenterology, 129(3): 837-45. [Abstract] [Full-text]
  14. Tumor-to-tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma.
    Pathol Int, 55(9): 574-9. [Abstract] [Full-text]
  15. Gene extraction for cancer diagnosis by support vector machines--an improvement.
    Artif Intell Med, 35(1): 185-94. [Abstract] [Full-text]
  16. Enhanced production of interleukin 6 in peripheral blood monocytes stimulated with mucins secreted into the bloodstream.
    Clin Cancer Res, 11(17): 6127-32. [Abstract] [Full-text]
  17. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells.
    Nat Med, 11(9): 992-7. [Abstract] [Full-text]
  18. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Jpn J Clin Oncol, 35(8): 453-63. [Abstract] [Full-text]
  19. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
    Am J Obstet Gynecol, 193(3): 668-74. [Abstract] [Full-text]
  20. Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.
    Hum Gene Ther, 16(9): 1075-86. [Abstract] [Full-text]
  21. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.
    Proc Natl Acad Sci U S A, 102(36): 12765-70. [Abstract] [Full-text]
  22. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Surgery, 138(2): 391-7. [Abstract] [Full-text]
  23. Proteomic analysis of colonic myofibroblasts and effect on colon cancer cell proliferation.
    Surgery, 138(2): 382-90. [Abstract] [Full-text]
  24. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.
    Biochem Pharmacol, 70(7): 1035-47. [Abstract] [Full-text]
  25. NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.
    Biochem Pharmacol, 70(7): 993-1000. [Abstract] [Full-text]
  26. Macrophages direct tumour histology and clinical outcome in a colon cancer model.
    J Pathol, 207(2): 147-55. [Abstract] [Full-text]
  27. Colon cancer prognosis prediction by gene expression profiling.
    Oncogene, 24(40): 6155-64. [Abstract] [Full-text]
  28. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease.
    J Pathol, 207(2): 164-76. [Abstract] [Full-text]
  29. Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy.
    Immunol Lett, 100(1): 88-93. [Abstract] [Full-text]
  30. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells.
    J Pathol, 207(2): 156-63. [Abstract] [Full-text]
  31. TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death.
    Cancer Lett, 229(1): 43-8. [Abstract] [Full-text]
  32. Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms.
    Cell Death Differ, 12(10): 1285-96. [Abstract] [Full-text]
  33. Metachronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and peripheral T-cell lymphoma unspecified: histologic, immunophenotypic, and molecular documentation.
    Onkologie, 28(8): 423-6. [Abstract] [Full-text]
  34. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Am J Physiol Gastrointest Liver Physiol, 289(4): G696-703. [Abstract] [Full-text]
  35. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer.
    Gut, 54(10): 1437-44. [Abstract] [Full-text]
  36. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
    Cancer Res, 65(18): 8442-7. [Abstract] [Full-text]
  37. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Eur J Nucl Med Mol Imaging, 32(9): 1115-23. [Abstract] [Full-text]
  38. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells.
    Mol Cancer Ther, 4(9): 1388-98. [Abstract] [Full-text]
  39. An evaluation of the ability of pifithrin-alpha and -beta to inhibit p53 function in two wild-type p53 human tumor cell lines.
    Mol Cancer Ther, 4(9): 1369-77. [Abstract] [Full-text]
  40. Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein.
    Mol Cancer Ther, 4(9): 1320-7. [Abstract] [Full-text]
  41. The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice.
    Mol Cancer Ther, 4(9): 1287-92. [Abstract] [Full-text]
  42. Induction of apoptotic cell death by 2'-hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-kappaB in TNF-alpha-treated SW620 colon cancer cells.
    Biochem Pharmacol, 70(8): 1147-57. [Abstract] [Full-text]
  43. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway.
    Mol Nutr Food Res, 49(9): 837-43. [Abstract] [Full-text]
  44. The role of the cytoskeleton in differentially regulating pressure-mediated effects on malignant colonocyte focal adhesion signaling and cell adhesion.
    Carcinogenesis, 26(10): 1687-97. [Abstract] [Full-text]
  45. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk.
    Cancer Epidemiol Biomarkers Prev, 14(9): 2066-75. [Abstract] [Full-text]
  46. Cancer, aging and the optimal tissue design.
    Semin Cancer Biol, 15(6): 494-505. [Abstract] [Full-text]
  47. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.
    Ann Oncol, 16(10): 1646-53. [Abstract] [Full-text]
  48. Primary gastrointestinal lymphomas: a radiological-pathological review. Part 1: Stomach, oesophagus and colon.
    Australas Radiol, 49(5): 353-64. [Abstract] [Full-text]
  49. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients.
    J Gastroenterol Hepatol, 20(10): 1578-83. [Abstract] [Full-text]
  50. A novel mouse model for segmental orthotopic colon cancer.
    Int J Cancer, 117(3): 335-9. [Abstract] [Full-text]
  51. Differences in optical properties between healthy and pathological human colon tissues using a Ti:sapphire laser: an in vitro study using the Monte Carlo inversion technique.
    J Biomed Opt, 10(4): 44022. [Abstract] [Full-text]
  52. Meat and fish consumption, APC gene mutations and hMLH1 expression in colon and rectal cancer: a prospective cohort study (The Netherlands).
    Cancer Causes Control, 16(9): 1041-54. [Abstract] [Full-text]
  53. Hand involvement in paraneoplastic syndrome: a case report.
    J Hand Surg [Am], 30(5): 1087-90. [Abstract] [Full-text]
  54. Endoscopic mucosal resection for colonic non-polypoid neoplasms.
    Am J Gastroenterol, 100(10): 2174-9. [Abstract] [Full-text]
  55. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination.
    Eur J Cancer, 41(14): 2071-8. [Abstract] [Full-text]
  56. Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines.
    Eur J Cancer, 41(14): 2160-9. [Abstract] [Full-text]
  57. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells.
    Bioorg Med Chem, 13(21): 6064-9. [Abstract] [Full-text]
  58. The feasibility and reliability of sentinel node mapping in colorectal cancer.
    Eur J Surg Oncol, 31(8): 854-62. [Abstract] [Full-text]
  59. Improved survival in cancer of the colon and rectum in Sweden.
    Eur J Surg Oncol, 31(8): 845-53. [Abstract] [Full-text]
  60. Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors.
    Biochimie, 87(11): 1005-10. [Abstract] [Full-text]
  61. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Eur J Surg Oncol, 31(8): 863-8. [Abstract] [Full-text]
  62. Missed lesions and false-positive findings on computed-tomographic colonography: a controlled prospective analysis.
    Endoscopy, 37(10): 937-44. [Abstract] [Full-text]
  63. Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer.
    Immunol Lett, 101(2): 154-9. [Abstract] [Full-text]
  64. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
    Oncogene, 24(43): 6533-44. [Abstract] [Full-text]
  65. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
    Leuk Lymphoma, 46(10): 1497-506. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2010 Colon Cancer Research Today. All Rights Reserved.



Colon Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)



Colon Cancer Books

CANCER, CHEMO AND BEYOND -Survivors and Their Unique Journeys

CANCER, CHEMO AND BEYOND -Survivors and Their Unique Journeys